Christopher S Hill's Insider Trades & SAST Disclosures

Christopher S Hill's most recent trade in Core Laboratories N.V. was a trade of 68,800 Performance Shares done . Disclosure was reported to the exchange on Feb. 13, 2025.

Share

Note

This is a custom search result for pattern Christopher S Hill.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Core Laboratories N.V.	Christopher S. Hill	SVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	68,800	68,800	-		-	Performance Shares
Core Laboratories N.V.	Christopher S. Hill	SVP & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Dec 2024	23,607	0	-		-	Performance Shares
Core Laboratories N.V.	Christopher S. Hill	SVP & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Dec 2024	23,607	95,656 (0%)	0%		0	Common Stock
Core Laboratories N.V.	Christopher S. Hill	SVP & CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.31 per share.	31 Dec 2024	14,719	80,937 (0%)	0%	17.3	254,786	Common Stock
Core Laboratories N.V.	Christopher S. Hill	SVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2023	52,718	52,718	-		-	Performance Shares
Core Laboratories N.V.	Christopher S. Hill	SVP & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Dec 2022	31,688	0	-		-	Performance Shares
Core Laboratories N.V.	Christopher S. Hill	SVP & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Dec 2022	31,688	62,642 (0%)	0%		0	Common Shares
Core Laboratories N.V.	Christopher S. Hill	SVP & CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.27 per share.	31 Dec 2022	12,470	50,172 (0%)	0%	20.3	252,767	Common Shares
Core Laboratories N.V.	Christopher S. Hill	SVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Feb 2022	43,236	43,236	-		-	Performance Shares
Core Laboratories N.V.	Christopher S. Hill	SVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Feb 2021	33,950	33,950	-		-	Performance Shares

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades